191 related articles for article (PubMed ID: 8057683)
1. Establishment and characterization of the T-cell line, EBT-8 latently infected with Epstein-Barr virus from large granular lymphocyte leukemia.
Asada H; Okada N; Hashimoto K; Yamanishi K; Sairenji T; Hirota S; Nomura S; Kitamura Y; Yoshikawa K
Leukemia; 1994 Aug; 8(8):1415-23. PubMed ID: 8057683
[TBL] [Abstract][Full Text] [Related]
2. [Large granular lymphocyte leukemia containing oligoclonal EB viral DNA].
Itoh K; Inaba T; Murakami S; Oku N; Takeda N; Ura Y; Shimazaki C; Nakanishi S; Nakagawa M; Taniwaki M
Rinsho Ketsueki; 1990 Oct; 31(10):1721-5. PubMed ID: 2174988
[TBL] [Abstract][Full Text] [Related]
3. Detection of Epstein-Barr virus genome in natural-killer-like cell line, YT.
Yoneda N; Tatsumi E; Kawano S; Teshigawara K; Oka T; Fukuda M; Yamaguchi N
Leukemia; 1992 Feb; 6(2):136-41. PubMed ID: 1313126
[TBL] [Abstract][Full Text] [Related]
4. Detection of clonal Epstein-Barr virus in malignant proliferation of peripheral blood CD3+ CD8+ T cells.
Chan LC; Srivastava G; Pittaluga S; Kwong YL; Liu HW; Yuen HL
Leukemia; 1992 Sep; 6(9):952-6. PubMed ID: 1325583
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection.
Tsuchiyama J; Yoshino T; Mori M; Kondoh E; Oka T; Akagi T; Hiraki A; Nakayama H; Shibuya A; Ma Y; Kawabata T; Okada S; Harada M
Blood; 1998 Aug; 92(4):1374-83. PubMed ID: 9694726
[TBL] [Abstract][Full Text] [Related]
6. Detection of Epstein-Barr virus DNA and EBV-determined nuclear antigen in angioimmunoblastic lymphadenopathy with dysproteinemia type T cell lymphoma.
Kon S; Sato T; Onodera K; Satoh M; Kikuchi K; Imai S; Osato T
Pathol Res Pract; 1993 Dec; 189(10):1137-44. PubMed ID: 8183733
[TBL] [Abstract][Full Text] [Related]
7. Generation of cells with morphological and antigenic properties of microglia from cloned EBV-transformed lymphoid progenitor cells derived from human fetal liver.
Ichigi Y; Naitoh K; Tokushima M; Haraoka S; Tagoh H; Kimoto M; Muraguchi A
Cell Immunol; 1993 Jun; 149(1):193-207. PubMed ID: 7685659
[TBL] [Abstract][Full Text] [Related]
8. Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies.
Harabuchi Y; Imai S; Wakashima J; Hirao M; Kataura A; Osato T; Kon S
Cancer; 1996 May; 77(10):2137-49. PubMed ID: 8640683
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of cell-free Epstein-Barr virus DNA in the plasma of patients with peripheral T-cell and NK-cell lymphomas and peripheral T-cell proliferative diseases.
Suwiwat S; Pradutkanchana J; Ishida T; Mitarnun W
J Clin Virol; 2007 Dec; 40(4):277-83. PubMed ID: 17996493
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus in a CD8-positive T-cell lymphoma.
Richel DJ; Lepoutre JM; Kapsenberg JG; Ooms EC; Boom WR; Boucher CA; Kluin PM
Am J Pathol; 1990 May; 136(5):1093-9. PubMed ID: 2161617
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of transformed human T-cell lines infected by Epstein-Barr virus.
Groux H; Cottrez F; Montpellier C; Quatannens B; Coll J; Stehelin D; Auriault C
Blood; 1997 Jun; 89(12):4521-30. PubMed ID: 9192776
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus (EBV) in enteropathy-associated T-cell lymphoma (EATL).
Pan L; Diss TC; Peng H; Lu Q; Wotherspoon AC; Thomas JA; Isaacson PG
J Pathol; 1993 Jun; 170(2):137-43. PubMed ID: 8393922
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of a novel cell line, TK-6, derived from T cell blast crisis of chronic myelogenous leukemia, with the secretion of parathyroid hormone-related protein.
Watanabe T; Kataoka T; Mizuta S; Kobayashi M; Uchida T; Imai K; Wada H; Kinoshita T; Murate T; Mizutani S
Leukemia; 1995 Nov; 9(11):1926-34. PubMed ID: 7475285
[TBL] [Abstract][Full Text] [Related]
14. Frequent detection of Epstein-Barr virus-infected B cells in peripheral T-cell lymphomas.
Ho JW; Ho FC; Chan AC; Liang RH; Srivastava G
J Pathol; 1998 May; 185(1):79-85. PubMed ID: 9713363
[TBL] [Abstract][Full Text] [Related]
15. Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1).
Klein G; Zeuthen J; Eriksson I; Terasaki P; Bernoco M; Rosén A; Masucci G; Povey S; Ber R
J Natl Cancer Inst; 1980 Apr; 64(4):725-38. PubMed ID: 6245297
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells.
Hart DN; Baker BW; Inglis MJ; Nimmo JC; Starling GC; Deacon E; Rowe M; Beard ME
Blood; 1992 Apr; 79(8):2116-23. PubMed ID: 1314113
[TBL] [Abstract][Full Text] [Related]
17. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP
Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055
[TBL] [Abstract][Full Text] [Related]
19. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
[TBL] [Abstract][Full Text] [Related]
20. Differences in EBNA2 and LMP-1 carboxy terminal region sequences of Epstein-Barr virus type A between the tumors in a multiple cancer patient.
Higa M; Kinjo T; Miyagi J; Sakumoto N; Iwamasa T; Kishaba M; Sunakawa H
Pathol Res Pract; 2001; 197(6):401-9. PubMed ID: 11432667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
